483
Contract Pharmacal CorporationFDA 483 - Contract Pharmacal Corporation - April 14, 2022
Discuss this record with AI
Record Details
An FDA inspection of Contract Pharmacal Corporation in Hauppauge, NY, revealed two observations related to manufacturing practices. Issues included inadequate cleaning of equipment, specifically tablet compression dies, and poor facility maintenance, with peeling paint and unpainted patches in tablet compression rooms.
Open in Dashboard
ID · 4c12d730-4f65-4b9a-8b3d-9516f80266c9